Femtosecond laser-assisted cataract surgery for the white cataract.
capsulotomy
femtosecond laser
treatment lasers
treatment surgery
white cataract
Journal
The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
22
03
2018
revised:
11
05
2018
accepted:
02
06
2018
pubmed:
17
6
2018
medline:
20
12
2019
entrez:
17
6
2018
Statut:
ppublish
Résumé
To report the capsulotomy and lens fragmentation outcomes of white cataracts managed with the femtosecond laser (FL). Outcomes of a prospective, observational consecutive case series of white cataracts (June 2012-November 2016) that underwent FL-assisted cataract surgery (FLACS) (Victus, Bausch+Lomb, Munich, Germany) at the Singapore National Eye Centre were audited. 58 eyes of 54 patients underwent FLACS. White cataract types included dry white (24 eyes), intumescent (28 eyes) and Morgagnian (6 eyes). Docking was level in 22 eyes (38.6%). Following FL, the anterior capsule level dropped in 20 eyes (34.5%). Incomplete capsulotomies occurred in 10 eyes (17.2%). Lens fragmentation attempted in 38 eyes was effective or partially effective in 31 eyes (81.6%). No anterior or posterior capsule tears occurred. LogMAR BCVA at 1 month was 0.073 (SD 0.09). Risk factors for incomplete capsulotomy were Morgagnian cataract and lens thickness (multiple logistic regression, p<0.01 and p=0.03, respectively). The main complication of FLACS in white cataracts was incomplete capsulotomy (17.2%), significantly associated with Morgagnian cataracts and increased lens thickness. Lens fragmentation was effected in four-fifths of white cataracts but should be avoided in Morgagnian cataracts due to possible overlap of the lens fragmentation plan and the anterior capsule.
Identifiants
pubmed: 29907631
pii: bjophthalmol-2018-312289
doi: 10.1136/bjophthalmol-2018-312289
doi:
Types de publication
Journal Article
Observational Study
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
544-550Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: S-PC is a speaker for AbbVie Pte Ltd., Alcon Laboratories, Allergan Inc, Bausch and Lomb Technolas, Carl Zeiss Meditec, Hoya Surgical Optics, Johnson & Johnson Vision, Santen Pharmaceutical Co. Ltd. and Ziemer Ophthalmic Systems. NS-WC and YY have no financial disclosures. S-ET is a speaker for PhysIOL.